Vigilant eyes will monitor South Africa’s first batch of vaccines
The department of health is also negotiating with manufacturers other than AstraZeneca to secure more than one type of vaccine
pharmacovigilance
You are viewing the M&G archive site.
Go to mg.co.za →
The Mail & Guardian has a new home.
Visit the new mg.co.za →